There are 210 papers on neurocognitive disorders in aging research: 9 trials and 108 observational studies in people, 4 in animals, 78 reviews.
15 new papers in 30 daysSee all 875 papers on neurocognitive disorders
At a glance
Neurocognitive disorders are linked with higher mortality and functional decline in human observational studies. A human trial reports that cognitive training combined with exercise lowers their risk after total hip replacement. Observational studies link older age, hypertension, depression, and sleep disorders with higher risk; physical frailty without cognitive impairment shows no clear link.
43 findings in 31 papers from 2016 to 2026, 5 of them since April 2026
“The incidence of NCD in the exercise group (10%, 5/50) was significantly lower than that in the control group (27.8%, 10/36) (P=0.032).”
- Human trial9
- Humans108
- Animals4
- In silico2
Effects
4Brain age
upin humans1
1 study
Brain age
upin humans1
Neurocognitive disorders increase brain age in humans (neurocognitive disorders) (Cohen's d = 3.27, 95 % CI 2.31-4.24, p < 0.05).
“neurocognitive disorders (Cohen's d = 3.27, 95 % CI 2.31-4.24, p < 0.05)”
Reviewneurocognitive disorders
Neuroimaging-derived brain age as a new promising biomarker in mental disorders
Neuroscience and biobehavioral reviews
Visuospatial performance
downin humans1
1 study
Visuospatial performance
downin humans1
Neurocognitive disorders are linked with lower visuospatial performance in humans (clinical group vs controls).
“The clinical group scored significantly lower than the control group, highlighting the impact of cognitive impairment on visuospatial performance.”
Humansclinical group vs controlsn = 113
Judgment Line Orientation Test: a proposal for an abbreviated version for the Brazilian population
AAIC 2025 abstract
Cognitive function
downin humans1
1 study
Cognitive function
downin humans1
Neurocognitive disorders are linked with worse cognitive function in humans (primary neurocognitive disorder vs no cognitive impairment or primary psychiatric disorder).
“The individuals with a primary neurocognitive disorder performed significantly poorer on most of the recognition scores compared to those with no cognitive impairment”
Humansprimary neurocognitive disorder vs no cognitive impairment or primary psychiatric disorder
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists
Fall severity
no changein humans1
1 study
Fall severity
no changein humans1
Neurocognitive disorders were not clearly linked with fall severity in humans (patients admitted for fall in a geriatric hospital).
“We did not find a statistically significant association between the severity of neurocognitive disorders evaluated with the MMSE and the serious falls.”
Humanspatients admitted for fall in a geriatric hospitaln = 100
Geriatrie et psychologie neuropsychiatrie du vieillissement
Upstream
1Physical frailty
no changein humans1
1 study
Physical frailty
no changein humans1
Physical frailty was not clearly linked with neurocognitive disorders in humans (without cognitive impairment).
“prefrail or frail old adults without cognitive impairment had no increased risk of incident NCD”
Humanswithout cognitive impairment
The journals of gerontology. Series A, Biological sciences and medical sciences
Associations
35Hypertension
upin humans2
2 studies
Hypertension
upin humans2
Hypertension is linked with a higher risk of neurocognitive disorders in humans.
“Among younger adults, lower educational levels, a native language other than Spanish, hypertension, and depression were risk factors for NCD”
Humans
AAIC 2025 abstract
Hypertension is linked with a higher risk of neurocognitive disorders in humans (urban-marginalized cohort in Lima, Peru).
“Risk factors for MCI and NCD included lower education, hypertension, and non-Spanish native language”
Humansurban-marginalized cohort in Lima, Peruboth (71% female)sn = 1,064
Alzheimer's & dementia : the journal of the Alzheimer's Association
Age
upin humans2OR 1.07
2 studies
Age
upin humans2OR 1.07
Age predicts neurocognitive disorders in humans (OR 1.07 (95% CI 1.02-1.13), p = 0.01).
“Age (odds ratio (95%CI) 1.07 (1.02-1.13); p = 0.01) and baseline cognitive impairment (odds ratio (95%CI) 2.1 (1.06-4.15); p = 0.03) were significant predictors of neurocognitive disorder 5 years after surgery.”
Humans5 years
Prevalence of neurocognitive disorders 5 years after elective orthopaedic surgery
Anaesthesia
Age is linked with a higher risk of neurocognitive disorders in humans.
“the older the age, the risk of developing neurocognitive disorders would increase”
Humansn = 257
Prevalence of neurocognitive disorders in a rural area of Argentina
Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)
Mortality
upin humans2HR 1.24
2 studies
Mortality
upin humans2HR 1.24
Neurocognitive disorders are linked with a higher risk of mortality in humans (aHR 1.54, 95% CI 1.19-1.98, p < 0.001).
“adjusted hazard ratio (aHR) [95% confidence interval (CI)] for a major NCD = 1.54 [1.19-1.98] (p < 0.001)”
Humanssolid cancer, adjusted for geriatric factors, cancer type, metastatic status, and treatment strategy12 monthsn = 2,784
The journal of nutrition, health & aging
Neurocognitive disorders are linked with a higher risk of mortality in humans (HR 1.24, 95% CI 1.23-1.25, p<0.0001).
“patients with a neurocognitive disorder had higher 30-day (hazard ratio 1·24 [95% CI 1·23-1·25]; p<0·0001), 90-day (1·25 [1·24-1·26]; p<0·0001), and 365-day mortality”
Humansn = 5,263,264
The lancet. Healthy longevity
Hybrid CNN-LSTM deep learning classifier
upin silico1
1 study
Hybrid CNN-LSTM deep learning classifier
upin silico1
hybrid CNN-LSTM deep learning classifier predicts neurocognitive disorders in silico (AUC-ROC 0.971, accuracy 95.1%).
“yielding an accuracy of 95.1%, precision of 93.4%, recall of 94.2%, and F1-score of 93.8%, with an AUC-ROC of 0.971.”
In silico
Advances in computational intelligence and robotics book series
Machine-learning
upin silico1
1 study
Machine-learning
upin silico1
machine-learning predicts neurocognitive disorders in silico (edge computing XAI model).
“Performance evaluation by common metrics shows the efficiency of the suggested approach.”
In silicoedge computing XAI model
Edge-Ready Explainable AI for Early Detection of Neurocognitive Decline
Advances in computational intelligence and robotics book series
CD4 lymphocyte count below 500 cells/μL
upin humans1
1 study
CD4 lymphocyte count below 500 cells/μL
upin humans1
CD4 lymphocyte count below 500 cells/μL is associated with neurocognitive disorders in humans (HIV infection with undetectable viral load while receiving antiretroviral therapy).
“with a CD4 lymphocyte count of less than 500 cells/μL, the odds of developing neurocognitive disorders (p=0.001) and liver cirrhosis (p=0.023) were significantly higher.”
HumansHIV infection with undetectable viral load while receiving antiretroviral therapy
Клиническая инфектология и паразитология
Physical restraint
upin humans1
1 study
Physical restraint
upin humans1
Neurocognitive disorders are linked with a higher risk of physical restraint in humans (difference 11.2%, 3.0-19.1).
“restraint episodes (difference 11.2%, 3.0-19.1; P < .001) compared to patients without neurocognitive disorders.”
Humansn = 334
The western journal of emergency medicine
Functional decline
upin humans1
1 study
Functional decline
upin humans1
Neurocognitive disorders are linked with a higher risk of functional decline in humans (difference 17.1%, 95% CI, 7.3-26.4).
“Patients with neurocognitive disorders (157/334, 47.0%) had higher rates of functional decline (difference 17.1%, 95% CI, 7.3-26.4; P < .001)”
Humansn = 334
The western journal of emergency medicine
Hong Kong population aged 60 years or above
upin humans1
1 study
Hong Kong population aged 60 years or above
upin humans1
Hong Kong population aged 60 years or above is associated with neurocognitive disorders in humans (community-dwelling and residential care home residents) (21.8% mild NCD, 9.7% major NCD).
“The age- and gender-adjusted prevalences of mild and major NCD were 21.8% and 9.7%, respectively, among adults aged 60 years or above in Hong Kong.”
Humanscommunity-dwelling and residential care home residentsn = 4,871
Hong Kong medical journal = Xianggang yi xue za zhi
UCH-L1
upin humans1
1 study
UCH-L1
upin humans1
Neurocognitive disorders are associated with UCH-L1 in humans.
“Post‐operatively, people with NCD had significantly higher levels of UHCL‐1, while non‐NCD patients had higher anti‐inflammatory IL‐10.”
Human trial3 monthsn = 44
AAIC 2025 abstract
IL-4
downin humans1
1 study
IL-4
downin humans1
Neurocognitive disorders are associated with IL-4 in humans.
“Pre‐surgical biomarker levels did not differ significantly between groups, except in anti‐inflammatory IL‐4 levels which were lower in those who developed NCD.”
Human trial3 monthsn = 44
AAIC 2025 abstract
Cognitive training + exercise
downin humans1
1 study
Cognitive training + exercise
downin humans1
Cognitive training + exercise lowers the risk of neurocognitive disorders in humans after total hip joint replacement surgery (10% (5/50) vs 27.8% (10/36), P=0.032).
“The incidence of NCD in the exercise group (10%, 5/50) was significantly lower than that in the control group (27.8%, 10/36) (P=0.032).”
Human trialafter total hip joint replacement surgeryn = 86
Minerva anestesiologica
All 35Fewer
Trial sponsors
Company2 trialsPhase 32,675 people
Sunnybrook Health Sciences Centre
2 trialsPhase 42,405 people
Oregon Health & Science University
1 trialPhase 4260 people
Second Affiliated Hospital of Wenzhou Medical University
1 trialPhase 442 people
1 trialPhase 3421 people
I.R.C.C.S. Fondazione Santa Lucia
1 trialPhase 275 people
1 trialPhase 240 people
1 trial1,900 people
Funding
20 grants since 2017National Institute on Aging$18.7MNational Institute of General Medical Sciences$2.3MUS Department of Veterans Affairs
The glymphatic system and perioperative neurocognitive disorder
National Institute on AgingColumbia University Health Sciences$692K2026–2031
Vascular contributions to HIV-associated Neurocognitive Disorders (HAND)
National Institute on AgingColumbia University Health Sciences$1.6M2022–2028
Biomarkers and Pathogenesis of Perioperative Neurocognitive Disorders
National Institute on AgingUniversity of Texas Hlth Sci Ctr Houston$581K2026–2031
National Institute on AgingPascall Systems$999K2023–2027
National Institute on AgingMassachusetts General Hospital$531K2022–2027
National Institute of General Medical SciencesUniversity of Illinois at Urbana-Champaign$436K2024–2029
Mechanism of Vascular Impairment in Neurocognitive Disorders
US Department of Veterans AffairsRalph H Johnson Va Medical Center2021–2024
National Institute on AgingUniversity of California, San Diego$71.6K2018–2024
Mechanisms Mediating Postoperative Neurocognitive Disorders
National Institute of General Medical SciencesMassachusetts General Hospital$197K2019–2025
Gouvernement du Canada | Canadian Institutes of Health ResearchUniversity of TorontoCA$17.5K2023–2024
How this record changed
Summary written from the findings.